Effects of prostaglandin E1 and E2 analogues on mucosal injury-induced, and on bacterial translocation promoted by, experimental intestinal obstruction

Journal of Investigative Surgery

Volumn 17, Issue 3, 2004, Pages 127-134

  Gurleyik, Gunay ^a,d   Ozturk, Erol ^a   Adaleti, Riza ^b   Gunes, Pembe ^c   Guran, Mithat ^a   Peker, Onder ^c   Saglam, Abdullah ^a  

^a Haydarpa a Numune Teaching Hospital   (Turkey)

^b Haydarpasa Numune Teaching and Research Hospital   (Turkey)

^c Haydarpa a Numune Research and Education Hospital   (Turkey)

^d NONE   (Turkey)

Author keywords

Bacterial translocation; Intestinal obstruction; Mucosal structure; PGE1; PGE2

Indexed keywords

PROSTAGLANDIN E1 DERIVATIVE; PROSTAGLANDIN E2 DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL OVERGROWTH; BACTERIAL TRANSLOCATION; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; HISTOPATHOLOGY; INTESTINE FLORA; MESENTERY LYMPH NODE; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; SMALL INTESTINE OBSTRUCTION; STATISTICAL SIGNIFICANCE; STOMACH MUCOSA INJURY; THICKNESS;

ALPROSTADIL; ANIMALS; BACTERIAL TRANSLOCATION; CYTOPROTECTION; DINOPROSTONE; INTESTINAL MUCOSA; INTESTINAL OBSTRUCTION; MODELS, ANIMAL; PROSTAGLANDINS; PROTECTIVE AGENTS; RATS; RATS, WISTAR;

EID: 3042772791     PISSN: 08941939     EISSN: None     Source Type: Journal    
DOI: 10.1080/08941930490446900     Document Type: Article

References (17)

1. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun. 1979;23:403-411.
2. Deitch EA. Simple intestinal obstruction causes bacterial translocation in man. Arch Surg. 1989;124:699-701.
3. Tibble JA, Sigthorsson G, Foster R, Bjarnason I. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat. Scand J Gastroenterol. 2000;35:802-807.
4. Mizoguchi H, Hase S, Tanaka A, Takeuchi K. Lack of small intestinal ulcerogenecity of nitric oxide-releasing indomethacin, NCX 530 in rats. Aliment Pharmacol Ther. 2001;15:257-267.
5. Deitch EA, Bridges WM, Ma JW, Ma L, Berg RD, Specian RD. Obstructed intestine as a reservoir for systemic infection. Am J Surg. 1990;159:394-401.
6. Schweizer E, Gassel A, Deltz D, Schroeder P. Morphologic and histologic alterations after small bowel transplantation: A comparison of different perfusion solutions. Transplant Proc. 1992;24:1087.
7. Antequera R, Bretana A, Cirac A, Brito A, Romera MA, Zapata R. Disruption of the intestinal barrier and bacterial translocation in an experimental model of intestinal obstruction. Acta Cient Venez. 2000;51:18-26.
8. Tiras S, Yilmaz R, Ersin S, Kara E, Ozbal O, Ozdedeli E, Kapkac M. Hydroxyethyl starch solution: Is it a new alternative way of treatment in bacterial translocation. Int Surg. 1998;83:250-252.
9. Akcay MN, Capan MY, Gundogdu C, Polat M, Oren D. Bacterial translocation in experimental intestinal obstruction. J Int Med Res. 1996;24:17-26.
10. Sagar PM, MacFie J, Sedman P, May J, Mancey-Jones B, Johnstone D. Intestinal obstruction promotes gut translocation of bacteria. Dis Colon Rectum. 1995;38:640-644.
11. Reis E, Kama NA, Coskun T, Korkusuz P, Ors U, Aksoy M, Kulacoglu S. Effects of octreotide and tocopherol on bacterial translocation in experimental intestinal obstruction: A microbiological, light and electron microscopical study. Hepatogastroenterology. 1997;44:656-663.
12. Akyildiz M, Ersin S, Oymaci E, Dayangac M, Kapkac M, Alkanat M. Effects of somatostatin analogues and vitamin C on bacterial translocation in an experimental intestinal obstruction model of rats. J Invest Surg. 2000;13:169-173.
13. Gao F, Ueda S, Horie T. Effect of a synthetic analog of prostaglandin E1 on the intestinal mucosa of methotrexate-treated rats. Anticancer Res. 2001;21: 1913-1917.
14. Helton WS, Garcia R. Oral prostaglandin E2 prevents gut atrophy during intravenous feeding but not bacterial translocation. Arch Surg. 1993;128:178-183.
15. Fukushima R, Alexander JW, Gianotti R, Pyles T, Ogle CK. Bacterial translocation-related mortality may be associated with neutrophil-mediated organ damage. Shock. 1995;3:323-328.
16. Fukushima R, Gianotti R, Alexander JW, Pyles T. The degree of bacterial translocation is a determinant factor for mortality after burn injury and is improved by prostaglandin analogs. Ann Surg. 1992;216:438-444.
17. Gionnetti R, Alexander JW, Pyles T, Fukushima R, Babcock GF. Prostaglandin E1 analogues misoprostol and enisoprost decrease microbial translocation and modulate the immune response. Circ Shock. 1993;40:243-249.